Hepion Pharmaceuticals, Inc. (HEPA) › EPS (Diluted)Hepion Pharmaceuticals, Inc. (HEPA) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2016: $-0.632017: $-2.042018: $-97.352019: $-5.952020: $-2.102021: $-0.472022: $-11.902023: $-616.072024: $-107.352025: $-0.88$-0.882016EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-0.88+99.2%2024$-107.35+82.6%2023$-616.07-5077.1%2022$-11.90-2431.9%2021$-0.47+77.6%2020$-2.10+64.7%2019$-5.95+93.9%2018$-97.35-4672.1%2017$-2.04-223.8%2016$-0.63—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share